UBS Group
ASPN icon

UBS Group’s Aspen Aerogels ASPN Stock Holding History

UBS Group’s Portfolio ASPN Stock Details ASPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-200
Closed -$3.52K – 9499
2024
Q1 		$3.52K Sell
200
-16,200
-99% -$239K ﹤0.01% 7736
2023
Q4 		$259K Buy
+16,400
New +$169K ﹤0.01% 5607

Other funds holding ASPN

KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GKFF
George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

UBS Group's ASPN Position: Q1 2026 in Review

UBS Group reduced its Aspen Aerogels (ASPN) stake by 40% in Q1 2026, selling an estimated $425K and leaving 189,229 shares worth $647K. The position accounts for ﹤0.01% of the portfolio, ranked #5885.

UBS Group first reported a position in ASPN in Q4 2014 and has held it in 39 quarters since. The position peaked at $5.28M in Q1 2024. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.

  • UBS Group held 189,229 shares of Aspen Aerogels worth $647K as of Q1 2026.
  • UBS Group sold 126,119 Aspen Aerogels shares in Q1 2026, an estimated $425K.
  • Aspen Aerogels made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5885 holding.
  • UBS Group first reported a position in Aspen Aerogels in Q4 2014 and has held it in 39 quarters since.
  • UBS Group's Aspen Aerogels position peaked at $5.28M in Q1 2024.
  • 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.